Abstract

BackgroundInterleukin (IL)13 is considered as a key downstream mediator in the development of Systemic sclerosis (SSc) fibrosis1. The recently described type 2 innate lymphoid cells (ILC) produce higher amounts of...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.